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Background:  Titanium  carbide  (TiC)  is  used  for ceramic  metal  composites  in several  indus-
tries and  is  regarded  as  a  nanomaterial  for catalyst  and  battery  applications.  However,  there
are very  few  studies  in regard  to  the toxicological  potential  of  TiC  nanoparticles  (NPs).
Objective: To  study  the  toxicodynamics  and  toxicokinetics  of  TiC NPs  in  Sprague Dawley
rats  in  acute  (24 h)  and  subacute  (28  days)  oral  administrations.  The  acute  doses  were  0.5,
5, 50,  300  and  1000  mg kg−1; the  subacute  doses  were  0.5  and  50 mg  kg−1.
Results: Organ  histopathological  examination  (esophagus,  stomach,  intestines,  spleen,  liver,
and kidneys)  indicates  the absence  of damage  at all  applied  doses,  in both  assessments.
In  the  acute  administration,  alkaline  phosphatases  increased  (5,  300  and  1000  mg kg−1),
ASAT increased  (1000 mg  kg−1)  and  bile  salts  decreased  (0.5 mg  kg−1). No  alterations  in
urine  parameters  (sodium,  potassium,  osmolarity)  were  found.  Acute  administration  of
TiC caused  mineral  changes  in  organs  (liver,  spleen,  kidneys).  TiC was  mostly  cleared  by
feces  excretion  24 h after  administration,  in subacute  administration  causing  variations  in
mineral absorption  (Mg,  Al, P, S,  Ca, Zn).  TiC  could  pass  the  intestinal  barrier  as  TiC traces
were  detected  in urine.
Conclusion: No sign  of  toxicity  was  found  after  oral  administration.  TiC was  excreted  mostly
in feces  producing  mineral  absorption  alterations.  Low  traces  were  retrieved  in urine,  indi-
cating that TiC  can  cross  the  intestinal  barrier.
rs.  Publ
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1. IntroductionNanomaterials (NMs) are actively used for a wide vari-
ety  of applications such as biocompatible materials [1],
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textile functionalization [2], coatings against UV radiation
[3],  drug delivery [4], and cell radiation delivery [5]. This
unprecedented progress has been associated with concerns
about  the possible health impacts of NMs. Hence, nanotox-
icology has been developed as a speciﬁc ﬁeld of study in
light  of reports indicating that NMs  may generally be more
toxic  than larger sized particles [6].
Among the NMs  already in use, titanium carbide (TiC)
is  a transition metal carbide with a face centered cubic
structure [7]. It presents noteworthy properties such as
is is an open access article under the CC BY-NC-SA license
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igh hardness (28–35 GPa), low density (4.93 g cm−3),
igh  melting point (3067 ◦C) and high Young’s modulus
300–480 GPa) [8]. Upon such mechanical and thermal
roperties the industry has adopted TiC for ceramic metal
omposites applications like tool bits, screws, industrial
nives and blades, compaction dies, and wear parts for
erospace and high stress industrial applications [9]. It has
een  used as catalyst supports for (bio)chemical reactions
10].  Today this compound is also considered because of
ts  capacity to improve battery technology as nanosheets
11], nanowire ﬁeld emitters [12], and nanorod catalysts
roduced from cotton cloth [8]. The relevance of TiC for
he  industry and specially its potential applications as a
M  was recognized a decade ago by government agen-
ies,  like NREL in USA, which has dedicated budgets for
ow-cost synthesis of TiC [13]. Unintended exposure of
iC  in the nanoscale to workers or individuals can take
lace  when products containing TiC are exposed to wear,
reakdown or undergo decommissioning. Within this con-
ext  it is necessary to ask whether such unintentional
xposure can have adverse effects to the health. Informa-
ion about the potential toxicological effects of TiC NPs is
ery  limited and scarce: N-hTERT keratinocytes exposed
o  TiC NPs resulted in LDH and IL8 release [14]; single
ose intra-tracheal instillation to rat lungs resulted in a
wo-fold  higher biopersistence, half time of 17 days, when
ompared to silicon carbide [25]; and, exposure to human
lasma resulted in very high pro-coagulant activity when
ompared to carbon black [15]. The gastrointestinal (GI)
athway is a major entry point for NMs  which may  arrive
ue  to (un)intentional ingestion or from inhaled parti-
les  through the respiratory tract mucociliary clearance
echanism [16–18], and can potentially end up in the
loodstream if the NMs  are able to pass the GI tract. This
tudy  addresses whether TiC NPs can cause toxicity to rats
hen  exposed via the GI pathway, using acute and subacute
ral  administration exposures, by studying the induced
oxicodynamics and TiC toxicokinetics.
. Materials and methods
.1.  Nanoparticle dispersions
Titanium  carbide NPs were obtained from Io-Li-Tec
Germany) and used without further treatment. No trace of
ndotoxin  was found using the endotoxin Limulus Amebo-
yte  Lysate kit (Lonza, Switzerland). For the physicochem-
cal characterization, a TiC NP dispersion was prepared at
 mg  mL−1 with MilliQ water and stirred at 400 rpm during
0  min, used immediately afterwards. For the acute and
ubacute administrations, a TiC NP stock dispersion was
repared weekly at 200 mg  mL−1 with tap water, stirred
uring 30 min  and stored at 4 ◦C. Then, daily fresh dilutions
ere prepared from the stock solution, previous vortex-
ng  for re-dispersion, at selected concentrations for in vivo
dministration. No surfactant was used to disperse the NPs,
ike  Pluronic F108, in order to avoid surface and particle size
istribution modiﬁcations [14,19,20]. It should be noted
hat  throughout this manuscript any mention of TiC implies
Ps  of TiC, unless otherwise speciﬁed.rts 1 (2014) 172–187 173
2.2. Nanoparticle characterization
The  particle size distribution of TiC was characterized
using a high resolution transmission electron microscope
(HRTEM) at an acceleration voltage of 200 kV (Monochro-
mated Tecnai 2001, Philips). A droplet (10 L) was left
to  dry on holey carbon ﬁlm supported on a cooper 200
mesh grid (Quantifoil R1.2/1.3). A Jeol FEG-SEM operated at
20  keV with an EDX (Energy Dispersive X-ray) detector was
used  to determine the bulk chemical composition of TiC.
Particle  size distributions (PSD) in number were
measured with a disc centrifuge DC24000 system (CPS
instruments Inc., USA). The measurement is based on the
centrifugal liquid sedimentation (CLS) method according
to  Stokes’ law using a 405 nm wavelength laser. This
method is also known as Differential Centrifugal Sedimen-
tation (DCS). The diameters measured are hydrodynamic
diameters, which for spherical particles provide the real
diameter (sphericity factor equal to 1). A certiﬁed calibra-
tion  standard of PVC microparticles (226 nm), was  used to
calibrate  all the measurements. Each measurement was
done  by injecting 0.1 mL  of the TiC NP dispersion into the
centrifugal disk (see Section 2.1 for details).
Speciﬁc surface area measurements were obtained by
the  BET method with an Accelerated Surface Area and
Porosimetry System (ASAP, Micromeritics 2010).
X-ray diffraction (XRD) measurements were performed
with a Siemens D5000 diffractometer equipped with a Cu
X-ray  source operating at 40 kV and 40 mA and a secondary
monochromator allowing selection of the K radiation of
Cu  ( = 1.5418 A˚).
Surface composition was  analyzed with an X-ray Photo-
electron Spectroscopy (XPS) system. The apparatus used
is  a SSX-100 system using Al K- X-rays, with spectra
recorded at 35◦ take-off angle. The analysis depth of XPS
is  around 5 nm.  Core-level lines (C1s, Si2p) were calibrated
to  the C 1s peak (284.6 eV) and Au 4f7/2 peak (84.0 eV).
The spectra were analyzed, ﬁtting the Gaussian function
to  the experimental curve, with a non-linear least squares
scheme, and using a Shirley background. Nominal resolu-
tion  was measured as full width at half maximum of 1.0 eV
(core-level  spectrum) or 1.5 eV (survey spectrum). Pristine
TiC  was  deposited as such on a gold slab.
2.3. Oral administration protocol
2.3.1. Animals
Nulliparous and non-pregnant female Sprague-Dawley
rats (Charles River, France) were used for acute oral toxicity
studies (age: 8 weeks, weight: 190–200 g) and for suba-
cute oral toxicity studies (age: 6 weeks, weight: 150–170 g).
Animals  were housed in a controlled environment at a
temperature of 20–22 ◦C, humidity of 45–65%, and 12 h
light/dark cycle. They had free access to tap water and to
commercial laboratory complete food (SAFE: Scientiﬁc Ani-
mal  Food & Engineering, Rats and mice. Product #A03-10,
batch 12037, Belgium). Rats were acclimatized to 2 weeks
before  housing in individual type III cages or in metabolic
cages (Techniplast COD.170013, Belgium). A daily moni-
toring  of stress, morbidity and mortality was  performed.
All animal experiments were done in agreement with the
gy Repo174 J. Laloy et al. / Toxicolo
local ethics committee for animals. Each dose was orally
administered between 9 and 10 am,  feces and urine were
collected the next day between 8 and 9 am.
2.3.2. Acute administration
To  evaluate the potential acute oral toxicity of TiC, the
OECD  (Organization for Economic Cooperation and Devel-
opment) guideline 420 for acute toxicity study of chemicals
was  used as a reference [21]. The recommended doses in
this  guideline had to be adapted for NPs due to technical
limitations. For example, the highest recommended dose
for  acute oral toxicity is 2000 mg  kg−1, nevertheless, such
high  concentration of NPs induced agglomerates to sedi-
ment  in aqueous media due to the NPs physicochemical
properties [14,22]. The maximal dose found to avoid sedi-
mentation was 1000 mg  kg−1.
The  administration of TiC was performed in a sequential
scheme adapted from the predetermined dose method [21]
as  follows: the lowest single dose of TiC dispersion was
administered to the ﬁrst group of rats. The administration
of a higher dose to the next group was done 24 h later. If at
least  one animal of the group should die or show any sign
of  external or visual toxicity, the NPs at that concentration
are considered as toxic and subsequent higher doses are
not  administered.
TiC  dispersions were prepared at 0.1, 1, 10, 60 and
200 mg  mL−1 and were administered at doses of 0.5, 5,
50,  300 and 1000 mg  kg−1 respectively, respecting a dose
volume of 5 mL  kg−1. The dispersions were administered
orally with a rigid stainless steel needle. The rats were
divided into six groups of ﬁve rats per group: a control
group which received only tap water whereas the ﬁve other
groups  received the TiC dispersions. Each group (n = 5)
was  divided into two sub-groups: 2 rats in conventional
type III cages and 3 rats individually housed in metabolic
cages. The rats were observed at 10 and 30 min, 18 and
24  h after administration. Afterwards, they were sacriﬁced
by  intraperitoneal injection of Nembutal (60 mg  kg−1), fol-
lowed  by an autopsy.
2.3.3.  Subacute administration
To  evaluate the potential subacute toxicity of TiC, OECD
guideline 407 for chemicals for subacute toxicity of chem-
icals  was used as a reference [23]. TiC dispersions were
prepared at concentrations of 0.1 mg  mL−1 and 10 mg  mL−1
to be administered at 0.5 mg  kg−1 and 50 mg  kg−1. The dis-
persions were administered orally using a rigid stainless
steel needle. Administration was performed once per day,
5  days per week during 4 consecutive weeks (28 days).
These low and mild doses were selected due to their peri-
odic  administration, based on the results obtained from the
acute  toxicity study. The total administered dose at the end
of  the assessment was 10 mg  kg−1 and 1000 mg  kg−1.
The rats were divided into three groups of six rats per
group: a control group receiving only tap water, a group
receiving the low dose (0.5 mg  kg−1) and a group receiv-
ing the mild dose (50 mg  kg−1). Each group (n = 6) was
divided into two sub-groups for the individual housing: 3
rats  in conventional type III cages and 3 rats in metabolic
cages. The rats were observed at 10 and 30 min, 18 and
24  h after administration. Rats were sacriﬁced at the endrts 1 (2014) 172–187
of  the 28 days by an intraperitoneal injection of Nembutal
(60 mg  kg−1), followed by an autopsy.
2.4.  Toxicity assessment
2.4.1.  Morphological and pathological examinations
Organs (esophagus, stomach, small and large intestines,
spleen, pancreas, kidneys and liver) were collected for
autopsy. All organs were ﬁxed in formalin 10%, embed-
ded in parafﬁn blocks and cut into slices (6 m thick).
The sections were placed on glass slides, and revealed by
a  staining technique using hematoxylin and eosin (H&E)
and  observed under an optical microscope (Olympus Pro-
vis  AX70, Japan) equipped with a camera (Zeiss AxioCam,
Japan). Histopathological examination was  conducted in
collaboration with the Institute of Pathology and Genetics
(IPG,  Belgium).
2.4.2. Plasma analysis
Blood  samples from the left ventricle of the heart
were extracted from all animals per group (n = 5 for acute
administration, n = 6 for subacute administration), using
a  21-gauge needle and collected in heparin and citrated
tubes. Plasma was obtained after centrifugation at 2000 × g
for  10 min. Sodium, potassium, glucose, total cholesterol,
total protein, alkaline phosphatase (AP), albumin and
amylase were analyzed. Parameters reﬂecting the liver
function, ASAT and ALAT, and the renal function, urea and
creatinine, were measured at the clinical biology labora-
tory  of CHU (Sart Tilman – Ulg, Belgium) using a HITACHI
917 (Roche, USA). Bile salts were analyzed at the Laboratory
of  Dr Collard (Belgium) using an Architect C8000 (ABBOTT,
Belgium).
2.4.3.  Urine analysis
Urinary  osmolarity was measured after a twofold
dilution in ultrapure water (MilliQ 18.2 M cm)  with a
micro-osmometer (Fiske Micro-osmometer Model 2010,
USA).  Sodium and potassium concentrations were mea-
sured  in urine samples after a twofold dilution in ultrapure
water (MilliQ 18.2 M cm)  by ﬂame spectroscopy (Instru-
mentation Laboratory 943, Italy).
2.4.4. Statistical analysis
Data  were analyzed with GraphPad Prism software
using a non-parametric Mann–Whitney test by comparing
control and treated samples.
2.5.  Detection of TiC in urine
Urines were collected from each rat, housed on
metabolic cages, every day during the experiment. After a
ﬁltration  procedure the urine ﬁltrates were analyzed with a
Jeol  FEG-SEM operated at 20 keV with an EDX (Energy Dis-
persive  X-ray) detector. The ﬁltration procedure was the
following: a fraction of the urine (2 mL)  was deposited on
a  650 nm ﬁlter inside an ultrafree centrifugal ﬁlter (Milli-
pore,  USA) and centrifuged at 10,000 × g during 2 min. Then
the  ﬁltrate was  collected and deposited on a 450 nm ﬁl-
ter  inside an ultrafree centrifugal ﬁlter, and submitted to
centrifugation at 10,000 × g during 2 min. Finally, the ﬁl-
trate  obtained was  deposited on a 100 nm ﬁlter inside an
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ltrafree centrifugal ﬁlter, and submitted once more to cen-
rifugation at 10,000 × g during 2 min. The ﬁlters of 220 and
50  nm were prepared for FEG-SEM observation. 500 L
f  2.5% glutaraldehyde in 0.1 M cacodylate buffer (com-
osed  of Na(CH3)2·AsO2·3H2O in distilled water at pH 7.4)
as  placed on the ﬁlter for 1 h. The glutaraldehyde solu-
ion  was removed by centrifugation at 10,000 × g during
 min, then 500 L of 0.2 M cacodylate buffer was  added.
ilters were washed with 0.2 M cacodylate buffer. The next
tep  was the dehydration of the sample with successive
aths of alcohol from 30 to 100 ◦C. A critical drying point
as  performed with a Balzers Critical Point Dryer (CPD)
30  (BAL-TEC Gmbh®, Germany). Afterwards, a thin layer
f  platinum (11.5 nm)  was deposited under argon atmo-
phere on ﬁlters with a metallizer Balzers union (BAL-TEC
mbh, Germany).
.6.  Detection of TiC and elemental composition analysis
n  feces and organs
Particle-Induced X-ray Emission (PIXE) was used to
uantify the amount of TiC and mineral content on feces
nd  organs. The fundamentals of the technique have been
xplained elsewhere [24,25]. It was preferred over other
echniques due to several reasons: (1) the sample prepa-
ation is simple (see next section) where there is no need
o  label the particles or to completely dissolve the target
aterial like with atomic absorption spectroscopy (AAS) or
nductively  coupled plasma atomic emission spectroscopy
ICP-AES); (2) there is not a restriction on the particle
ize to measure; (3) it is a non-destructive technique;
4) high volume statistics (see PIXE analysis section); and
5)  the technique has a ppm-level of sensitivity similar
o  AAS [26], which is better than energy dispersed X-ray
pectroscopy (EDX), a similar technique using electrons
nstead of ions [25].
.6.1.  Sample preparation
Feces  were collected from each rat everyday on both
cute and subacute toxicity studies. The dose (or ﬁrst dose
n  subacute administration) was applied on day 0. This
eans  that, for example, the concentrations reported for
ay  1 correspond to the collected feces produced during
he  prior day. Rat liver, kidneys and spleen were prepared
or  elemental quantiﬁcation. Both feces and organs were
repared into pellets for ion beam analysis. The feces were
ried  in an oven at 60 ◦C for 24 h. The daily amount of rat
eces  allowed the preparation of up to 3 pellets per rat,
ll  of them were measured and averaged. Each pellet of
eces  was prepared with the following procedure: feces
ere  weighed and then chromium nitride (Cr2N) powder
Goodfellow, 99% purity, 45 micron particle size) was  added
n  a ratio of 7–10% of the feces weight. Both feces and
r2N powder were then subjected to ball milling in order
o  get a homogeneous powder mixture. This mixture was
nally  hard pressed into a pellet (diameter: 2 cm,  thick-
ess: 1 mm).  In the case of organs, they were dried in an
ven  at 37 ◦C for 24 h, and then weighed. Organs were dry-
rozen  with liquid nitrogen [27], powdered by ball milling
ith  7–10% of Cr2N powder, and then hard pressed to pro-
uce  pellets (diameter: 2 cm,  thickness: 1 mm).  The reasonrts 1 (2014) 172–187 175
for  mixing feces or organs with Cr2N is to avoid charge
accumulation in the sample during ion beam irradiation,
and to use Cr as an internal standard for quantitative mea-
surements [25]. Chromium was  selected because it is not
present  in the biological matter or as an impurity in TiC,
and  it does not interfere with other elements during the
PIXE  measurements.
2.6.2. PIXE analysis
Ion  beam measurements were performed with the
ALTAÏS accelerator of the University of Namur. The incident
ion  beam was  2.5 MeV  protons, and both Particle-Induced
X-ray Emission (PIXE) and Rutherford Back-Scattering
(RBS) measurements were done simultaneously. The
geometry and setup for the measurements have been
described previously [25]. Brieﬂy, with respect to the beam
direction: the sample was  tilted at 45◦, a Canberra LEGe
(Low  Energy Germanium) detector was  located at 90◦ for
PIXE  measurements, and a Canberra PIPS detector was
positioned at 145◦ for RBS measurements. An aluminum
collimator (1 mm aperture, 0.2 mm thick) was  used in front
of  the PIXE detector. The samples were mounted on a rotat-
ing  device providing a total scan area of 140.5 mm2.
PIXE measurements were validated with two standards
from the International Atomic Energy Agency (IAEA 153
and  IAEA 155). The results are in agreement with respect
to  the reported concentrations (better than 5%) [28,29].
The  addition of 7–10 wt.% Cr2N to the samples was  chosen
as  a best compromise between the X-ray yield from the
biological material and TiC with respect to the X-ray
attenuation caused by a heavy-element inclusion into
the  matrix (biological matter). Data analysis included this
attenuation factor. A 2.5 MeV  proton beam has a pene-
tration depth of 62.32–61.95 m into a biological matrix
containing 7–10 wt.% Cr2N, respectively [30]. Therefore,
small variations in the amount of Cr2N powder into the
biological matrix have less than 5% change in the measured
volume per sample. For a biological matrix under similar
analysis conditions the limit of detection (LOD) and limit
of  quantiﬁcation (LOQ) of Ti is 10 and 33 ppm, respectively
[25]. Other minerals have been measured in either feces
or  organs: magnesium (Mg), aluminum (Al), phosphorous
(P), sulfur (S), calcium (Ca), and zinc (Zn). Their respective
LOD and LOQ are presented as element (LOD, LOQ) in ppm:
Mg  (87, 290), Al (84, 280), P (32,107), S (24, 80), Ca (60,
200),  Zn (24, 80).
2.6.3.  Optimal dose group analysis
The trace elements of the diet ingested by rats were
measured by PIXE [31]. From the average diet ingested by
rats,  16.9 mg,  mineral Ti in the diet accounts for 11.26 mg.
For  administered doses of 0.5 and 50 mg kg−1, Ti content
accounts for 0.091–0.122 mg  and 9.1–12.2 mg  (average rat
weight:  182 g at day 1, 244 g at day 28), respectively.
Therefore, of these two  groups, only the high dose group
(50  mg  kg−1) was measured by differentiating it from the
ingested Ti in the food.2.6.4.  Statistical analysis
Three  samples (n = 3) were measured per condition.
Means were calculated as the average of the samples per
176 J. Laloy et al. / Toxicology RepoFig. 1. TEM image of pristine TiC. The average diameter is 39.6 ± 8.9 nm.
Scale bar: 100 nm.
condition, and error bars represent the propagation of
uncertainty. Statistical signiﬁcance of the biodistribution
data was analyzed by the Holm–Sidak method (two-way
ANOVA) with the SigmaStat software. Statistical signif-
icance analysis was carried out for same day samples
(control versus treated animals) and different day samples
(control versus treated animals, and treated versus treated
animals). Signiﬁcant results were divided into p < 0.05,
p  < 0.01, and p < 0.001.
3. Results
3.1. Nanoparticle and dispersion characterizationA HRTEM image of TiC is shown in Fig. 1. Table 1
summarizes the physicochemical characterizations of TiC
NPs,  which have been previously reported [14,25]. Brieﬂy,
pristine TiC is composed of sphere-like particles of cubic
Table 1
TiC  physicochemical characterization.
Physical properties Mea
Average diameter (TEM) [nm] 39.6
Primary particle diameter (CLS) [nm]c 18 
Agglomerates/aggregates diameter (CLS) [nm]c 161
Primary particles (CLS) [%]c,d 75 
Agglomerates/aggregates (CLS) [%]c,d 25 
Surface area (BET) [m2 g−1] 16 
Crystallography (XRD) Cub
Chemical composition Ti C 
Bulk composition (EDX) [at.%] 36.9 59.5 
Surface composition (XPS) [at.%] 8.1 64.5 
a Iolitec technical data sheet 05/01/2007.
b Product purity reported as TiC only.
c Hydrodynamic diameters from water dispersion, derived from number-based
d Cut-off size between primary particles and agglomerates/aggregates at 90 nmrts 1 (2014) 172–187
structure with an average diameter of 39.6 ± 8.9. The spe-
ciﬁc  surface area, the surface that can potentially interact
with the external media (dispersant media, biomolecules
and/or biological systems), was 16 m2 g−1. The bulk of TiC
is  close to the 1:1 Ti:C ratio expected to be found. The sur-
face  of TiC is dominated by a carbon and oxygen rich layer,
most  likely due to environmental contamination. The anal-
ysis  of TiC dispersion in water was  done by CLS, measuring
the  primary (individualized) particles (PPs) in 18 nm and
the  aggregates in 161 nm.  The PPs account for 75% of the
number of particles, using a cut-off diameter of 90 nm that
separates the distributions of PPs and aggregates.
3.2. Acute toxicity
The  animals received a single dose of TiC (0.5, 5, 50, 300
or  1000 mg kg−1) dispersed in tap water using a stainless
steel needle. All the animals survived the single adminis-
tration of TiC, regardless of the concentration, and did not
show  any sign of discomfort (lethargy, nausea, vomiting or
diarrhea)  during the 24 h following TiC administration.
Twenty-four hours after the administration, all the
animals were submitted to a detailed autopsy. From a
macroscopic point of view, no change was observed in
the  analyzed organs (esophagus, stomach, small and large
intestines, liver, spleen or kidneys). Similarly, no signiﬁcant
difference was  observed in the weight of organs between
treated and control animals and these weights were in the
physiological range described for rats [32].
Several blood parameters were measured (Table 2):
sodium, potassium, glucose, total cholesterol, AP, albu-
min,  parameters reﬂecting the liver function (ASAT and
ALAT),  bile salts and parameters reﬂecting the kidney func-
tion  such as urea and creatinine. A signiﬁcant decrease of
plasmatic  AP was  observed for the groups treated with 5,
300  and 1000 mg  kg−1 of TiC. ASAT increased for animals
treated with 1000 mg  kg−1 of TiC, suggesting a potential
alteration of liver function. A decrease of bile salts was
observed in animals treated with 0.5 mg  kg−1 of TiC, com-
pared with control animals. The absence of increase in the
urea  and creatinine concentrations suggested that the kid-
ney  function was  likely not affected by TiC administration.
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Table 2
Plasmatic concentration of acute and subacute TiC-treated groups compared with the control group.
Exposure Acute Subacute
Parameters Control Group 1 Group 2 Group 3 Group 4 Group 5 Control Group 1 Group 2
(physiological  range)a Water 0.5 mg  kg−1 5 mg kg−1 50 mg kg−1 300 mg  kg−1 1000 mg kg−1 Water 0.5 mg kg−1 50 mg kg−1
Sodium
130–150 (mmol·L−1)
143.2 ± 0.8 142.0 ± 0.7 142.6 ± 0.9 143.0 ± 1.2 141.5 ± 1.01 143.8 ± 1.3 138.8 ± 1.7 139.7 ± 1.4 104.7 ± 0.8
Potassium
4.5–6.0  (mmol  L−1)
3.7  ± 0.6 3.5 ± 0.3 3.1 ± 0.3 3.7 ± 0.4 3.6 ± 0.5 3.6 ± 0.3 3.2 ± 0.1 3.3 ± 0.3 3.2 ± 0.4
Glucose
0.89–1.83  (g L−1)
1.3 ± 0.2 1.2 ± 0.2 1.1 ± 0.1 1.2 ± 0.2 1.3 ± 0.2 1.2 ± 0.1 1.3 ± 0.2 1.4 ± 0.2 1.3 ± 0.4
Urea
0.32–0.54  (g L−1)
0.4 ± 0.04 0.4 ± 0.04 0.3 ± 0.03 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.03 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1
Creatinine
3.9–22.9  (mg  L−1)
2.4 ± 0.2 2.2 ± 0.1 2.5 ± 0.2 2.7 ± 0.3 2.9 ± 0.5 2.7 ± 0.3 2.8 ± 0.3 2.7 ± 0.3 2.9 ± 0.3
Total  proteins
59.0–84.0 (g L−1)
53.0 ± 2.7 53.2 ± 1.1 52.4 ± 1.95 53.4 ± 2.4 52.0 ± 1.4 55.2 ± 1.5 57.5 ± 2.7 58.3 ± 1.9 58.8 ± 2.9
Albumin
32.0–43.0  (g L−1)
37.8 ± 1.5 38.2 ± 1.8 37.4 ± 1.5 38.2 ± 2.2 37.5 ± 1.3 39.6 ± 1.1 40.2 ± 2.4 41.2 ± 2.3 41.3 ± 3.0
AP
39–216  (UI L−1)
204.8 ± 23.4 182.4 ± 43.3 157.4 ± 26.8* 170.2 ± 34.7 115.0 ± 18.01** 136.2 ± 24.7** 122.2 ± 26.1 130.8 ± 50.2 145.7 ± 47.0
ASAT
39–92  (UI L−1)
76.8 ± 9.4 83.8 ± 9.9 80.0 ± 8.5 76.3 ± 11.6 82.0 ± 5.8 101.8 ± 6.95* 105.0 ± 17.8 88.8 ± 13.6 99.3 ± 15.7
ALAT
17–50  (UI L−1)
24.0 ± 3.9 25.6 ± 5.7 24.0 ± 3.5 26.0 ± 4.3 24.0 ± 2.6 35.0 ± 14.4 29.0 ± 5.4 40.3 ± 14.5 36.0 ± 13.1
Amylase
NAb (UI·L−1)
808.0 ± 215.3 851.4 ± 212.8 844.0 ± 124.5 927.2 ± 147.4 834.5 ± 206.1 934.0 ± 168.5 1032.0 ± 179.1 1091.0 ± 189.2 1174.0 ± 257.1
Total  cholesterol
0.5–1.0 (g L−1)
0.68 ± 0.07 0.78 ± 0.10 0.84 ± 0.21 0.84 ± 0.14 0.72 ± 0.22 0.85 ± 0.17 0.9 ± 0.1 0.9 ± 0.2 0.9 ± 0.2
Bile  salts
0–40 (M)
12.4 ± 1.7 8.1 ± 1.3* 12.6 ± 2.4 10.2 ± 2.3 11.7 ± 2.2 13.3 ± 4.6 13.2 ± 7.9 6.4 ± 2.5 6.2 ± 1.9
Mean ± SD, n = 5 for acute administration, n = 6 for subacute administration. Statistical studies were performed for each studied biochemical parameter between control group and treated group using a
non-parametric Mann–Whitney test (GraphPad Prism 5.0 software). AP: alkaline phosphatases; ASAT: aspartate amino-transferase; ALAT: alanine amino-transferase.
a Physiological range (from [32]).
b NA: not available. Statistical analysis: non parametric Mann–Whitney test.
* Statistical signiﬁcance between control and treated animals: p < 0.05.
** Statistical signiﬁcance between control and treated animals: p < 0.01.
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Fig. 2. Histopathological examination of large intestine of TiC treated animals after acute administration at concentration of 0.5 (A and C) and 1000 mg kg−1
(B and D). Arrows indicate the presence of TiC agglomerates in intestine lumen. H&E, 400× (A and B) and 1000× (C and D).
inistratiFig. 3. Histopathological examination of the renal cortex after acute adm
TiC treated groups. CR: renal corpuscles. H&E, 400×.
Histopathological examinations showed that the esoph-
agus,  stomach and intestines were not affected by the
administration of TiC NPs (data not shown). The epithe-
lium of the GI tract (esophagus, stomach, small and large
intestines) did not exhibit irregularities, even at the dose
Fig. 4. Histopathological examination of the liver after acute administration fro
treated  groups. H&E, 200×.on from selected animals. (A) Control group, (B) 0.5 and (C) 1000 mg kg−1
of  1000 mg  kg−1. TiC NPs can be observed in the large
intestine lumen of the animals regardless of the concentra-
tion administered (Fig. 2). Kidneys examination of control
and  TiC treated groups, see Fig. 3, showed no anomalies
between control and treated groups: the medullar and the
m selected animals. (A) Control group, (B) 0.5 and (C) 1000 mg kg−1 TiC
J. Laloy et al. / Toxicology Repo
Table 3
Summary of rat feces elemental quantiﬁcation from PIXE analysis of con-
trol  and treated groups from the acute administration study.
Day on
study
Weight  (g,
mean  ± SD)
Fecal mass
collected (mg)
Elemental analysis
(ppm,  mean ± SD)
Ti
Control group
1  205.67 ± 8.74 2479 174 ± 11
2  207.67 ± 8.74 1680 462 ± 14
3  209.67 ± 8.74 1916 180 ± 13
Treated group
c
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n
c
s
a
3
t
r
t
t
i
t
3
a
P
g
F
b
H
*1  204.67 ± 14.15 2904 4485 ± 26
2  206.67 ± 14.15 2588 201 ± 12
3  208.67 ± 14.15 2510 182 ± 13
ortex exhibited a normal aspect, indicating no renal dam-
ge.  Liver examination showed that its architecture was
ot  affected by TiC administration (Fig. 4). No steatosis,
holestase or hepatocellular insufﬁciency or other sign of
uffering  were observed. Spleen examination showed the
bsence  of damage (data not shown).
.2.1. Feces analysis: acute administration
Feces from rats subjected to an acute oral administra-
ion were analyzed from days 1 to 3 in order to clarify the
ate  of excreted TiC. The procedure was the same applied
o  the subacute administration samples. The data revealed
hat  TiC is completely expelled within the day it was  admin-
stered.  Table 3 summarizes the absolute concentrations of
he  control and treated groups.
.2.2. Organs analysis: acute administration after 24 h
nd 7 days
Several organs were prepared for element analyses by
IXE:  liver, kidneys, and spleen. The rats were given a sin-
le  dose of TiC by oral administration and were sacriﬁced
ig. 5. PIXE analysis of element variation in different rat organs at 1 day and
een  normalized with respect to rat weight and control concentrations. (A) Live
olm–Sidak  method. Statistical signiﬁcance between: control and treated animal
*,  ×× indicate p < 0.01; +++,***, ××× indicate p < 0.001.rts 1 (2014) 172–187 179
one  or 7 days later. Fig. 5 summarizes the organs elemental
analyses. Data were normalized with respect to their con-
trol  concentrations. An increase in TiC was  found on the
spleen  at day 7, when compared to the concentration at day
1.  The result suggests that TiC may  pass through the intesti-
nal  barrier. Organs mineral composition are presented in
Fig.  5A–C for liver, kidneys, and spleen, respectively. Liver
presents a statistical variation in the quantity of Al found
on  day 1, and the spleen presents a statistical variation
in the quantity of Ca between days 1 and 7. Both liver
and  kidneys follow a qualitative similar behavior: taking
as  example P and S, both of them present at higher con-
centrations on day 1 compared to day 7. This is contrary to
the  concentrations measured for spleen. Table 4 summa-
rizes  the absolute concentrations of the control and treated
groups.
3.3.  Subacute toxicity
The  subacute toxicity study (28 days) was  performed
with TiC dispersions administered orally at a concentration
of 0.5 or 50 mg  kg−1 during four weeks, 5 days a week.
The rats were observed after 10 and 30 min, 18 and 24 h
after  each administration and their behavior was  evalu-
ated.  Each animal survived the treatment with TiC on both
concentrations, and did not show any sign of discomfort
(lethargy, nausea, vomiting or diarrhea) during the whole
experiment. The animals were weighed every day dur-
ing  the experiment, no abnormal weight variations were
observed during this period. At the end of the experiment,
the animals weighed between 200 and 240 g which cor-
responded to the normal weight range of Sprague-Dawley
rats of eleven weeks (Sprague-Dawley age/weight curve,
Charles River). Food and water consumption were also
quantiﬁed. No change in both consumptions was  observed
 7 days after acute administration of 50 mg kg−1 of TiC. All plots have
r, (B) kidneys, (C) spleen. Statistical analysis: two  way ANOVA using the
s (+), treated animals (*), control animals (×). +, *, × indicate p < 0.05; ++,
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Table 4
Summary of rat organ elemental quantiﬁcation from PIXE analysis of control and treated at 1 day and seven from the acute administration study.
Organ Elemental analysis (ppm, mean ± SD)
Mg  Al P S Ca Ti Mn Fe
Control group (24 h)
Liver 1981 ± 240 792 ± 65 12,424 ± 42 7714 ± 26 132 ± 13 85 ± 5 292 ± 53 551 ± 14
Kidneys  7833 ± 900 1757 ± 241 33,851 ± 159 23,038 ± 99 534 ± 43 281 ± 18 820 ± 210 651 ± 40
Spleen  3146 ± 867 4201 ± 243 35,475 ± 152 18,295 ± 87 318 ± 49 304 ± 19 1334 ± 233 4124 ± 73
Treated  group (24 h)
Liver 2117 ± 285 1416 ± 78 15,274 ± 50 9732 ± 31 121 ± 16 79 ± 6 376 ± 49 750 ± 16
Kidneys  7954 ± 1068 3384 ± 290 39,151 ± 182 25,883 ± 115 564 ± 49 224 ± 21 742 ± 194 724 ± 46
Spleen  6773 ± 751 1891 ± 205 32,272 ± 140 16,445 ± 79 210 ± 46 227 ± 16 865 ± 179 3215 ± 62
Control  group (7 days)
Liver  2586 ± 232 506 ± 62 12,728 ± 42 7368 ± 25 102 ± 13 65 ± 5 302 ± 47 606 ± 13
Kidneys  9155 ± 974 1560 ± 262 37,634 ± 177 25,559 ± 110 534 ± 47 251 ± 19 1018 ± 206 726 ± 43
Spleen  4633 ± 866 2287 ± 240 37,847 ± 159 19,737 ± 92 246 ± 51 285 ± 18 990 ± 200 3604 ± 70
Treated  group (7 days)
8711
26,985
21,318Liver  2640 ± 270 778 ± 72 13,849 ± 47 
Kidneys  4802 ± 1035 2047 ± 278 40,066 ± 185 
Spleen  4944 ± 926 2805 ± 258 40,636 ± 171 
during the 28 days of experiment, control or treated groups.
On  average, animals consumed daily 91 g kg−1 of food and
114  mL  kg−1 of water. This consumption was within the
physiological range for rats [33]. Twenty-eight days after
the  ﬁrst administration of TiC, each animal was  submit-
ted  to a detailed autopsy. No change was observed on the
GI  tract organs, liver, spleen and kidneys from a macro-
scopic point of view. There was no signiﬁcant difference in
the  organs weight between the control and the TiC treated
groups.
Histopathological analyses of different organs (esoph-
agus, stomach, intestines, liver, kidney, and spleen) were
performed. The histopathological examination of the GI
tract  (after acute administration) showed no differences
between the control group and the TiC treated groups (data
not  shown). Similarly, spleen, kidney (renal cortex) or liver
(parenchyma) was without anomalies for TiC treated rats
(data  not shown).
Twenty-eight days after the ﬁrst TiC administration,
blood samples were collected from the intracardiac cavity
during  necropsy. All the measured plasmatic parameters
were in the normal range described for rats in control and
treated  groups [33], see Table 2.
3.3.1. Feces analysis: subacute administration
Feces from selected days were analyzed by PIXE in
order to evaluate their TiC content following subacute oral
administration. The TiC content was evaluated from the
Ti  signal (see Fig. 6A). All the feces of each selected day
(control and TiC treated groups) were analyzed. Data from
the  TiC treated group were normalized with the data from
the  control group from the same selected day. Addition-
ally, the data were normalized with respect to the average
rat  weight of the selected day to account for the increase
of  dosed TiC with an increased weight. During the days
of  administration (weekdays) Ti content did ﬂuctuate and
presented  an average concentration ratio of 20.3 ± 7.8;
during  the days without administration (weekends) the
concentration ratio was similar to those of the control
group. In addition to Ti, other minerals were quantiﬁed ± 29 100 ± 14 64 ± 5 270 ± 44 676 ± 15
 ± 115 583 ± 51 185 ± 20 670 ± 163 736 ± 43
 ± 99 382 ± 55 291 ± 20 1334 ± 212 4400 ± 83
such as Mg,  Al, P, S, Ca, and Zn (see Fig. 6B–H). Two general
trends are observed in the fecal release of these minerals:
(1) when rats were administered TiC, their mineral release
was  lower than control concentrations: ∼50% lower on day
1  and reducing down to ∼25% on day 28; and (2) when rats
were  not administered with TiC (weekends, here reported
days  5, 11 and 12) their release was  higher than control con-
centrations, ∼150–200% on day 5 and reducing to ∼110%
on day 11. Table 5 summarizes the absolute concentrations
of the control and treated groups.
3.3.2. Elimination of TiC by urine excretion
Urine samples were collected each day and quantiﬁed.
The average daily urine volume collected was  58.5 mL kg−1,
which  is within the physiological reference range described
for  rats [33]. No differences were observed in osmolarity,
sodium and potassium of urine ﬁltrates in both 0.5 and
50  mg  kg−1 TiC subacute treated groups compared to the
control  group, see Fig. 7.
Urine ﬁltrates were observed by electron microscopy
(FEG-SEM) after a ﬁltration and centrifugation process in
order  to detect the possible presence of TiC. Sample images
from  the urine of a TiC treated rat is shown in Fig. 8 from
the  acute and subacute administration, showing granular
agglomerations even with the low dose of 0.5 mg  kg−1 after
acute  administration, see Fig. 8A. These granular agglom-
erations were found only in the urine of treated rats in both
acute  and subacute administration. An EDX analysis on
these  agglomerations, see Fig. 8D, exhibits a strong Ti sig-
nal,  qualitatively conﬁrming that TiC can pass the intestinal
barrier.
4.  Discussion
The design idea of this study was that the obtained
results can be used, tracked and compared with other NM
studies,  regardless of their individual signiﬁcance. There
are  two  common deﬁciencies to achieve this objective.
Firstly, many papers on the toxicity of NMs, especially
pre-2006, lack a proper physicochemical characterization
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Table 5
Summary of rat feces elemental quantiﬁcation from PIXE analysis of control and treated groups from the subacute administration study.
Day
on
study
Weight  (g,
mean  ± SD)
Fecal mass
collected
(mg)
Elemental analysis (ppm, mean ± SD)
Ti Mg  Al P S Ca Mn Fe Zn
Control group
1  158.67 ± 5.03 2801  184 ± 13 94,251 ± 830 4006 ± 182 77,550 ± 128 8069 ± 44 58,542 ± 75 1555 ± 92 1987 ± 34 677 ± 23
5  170.67 ± 1.15 2905 157 ± 9 66,964 ± 565 2924 ± 123 49,715 ± 82 5556 ± 29 39,400 ± 50 1176 ± 71 1484 ± 24 559 ± 16
6  174.67 ± 2.52 2647 173 ± 9 95,568 ± 838 4019 ± 184 81,645 ± 130 7924 ± 43 64,002 ± 80 1538 ± 81 1874 ± 34 662 ± 24
7  178.67 ± 3.51 2884 208 ± 20 111,557 ± 988 4620 ± 222 97,363 ± 156 9298 ± 51 74,128 ± 94 1578 ± 79 2208 ± 39 866 ± 27
8  181 ± 2 3061 171 ± 12 80,966 ± 741 3012 ± 165 67,261 ± 114 7259 ± 40 50,663 ± 69 1360 ± 85 1672 ± 31 572 ± 21
9  178.33 ± 3.21 2160 212 ± 16 105,602 ± 936 4597 ± 207 91,109 ± 148 9052 ± 49 69,640 ± 89 1794 ± 100 2133 ± 42 705 ± 30
10  181.33 ± 8.02 2180 205 ± 14 108,734 ± 834 4800 ± 183 89,159 ± 131 8895 ± 44 73,141 ± 83 1804 ± 90 2312 ± 37 839 ± 27
11  184.67 ± 6.81 2567 173 ± 13 97,250 ± 796 4540 ± 175 81,799 ± 125 7722 ± 42 64,794 ± 76 1470 ± 81 2052 ± 34 673 ± 25
12  188 ± 6.93 2503 196 ± 14 103,993 ± 863 4361 ± 190 93,649 ± 139 7923 ± 45 72,535 ± 85 1588 ± 88 2005 ± 36 762 ± 25
14  194 ± 4.36 2282 218 ± 15 124,836 ± 914 5145 ± 193 98,909 ± 142 8678 ± 47 71,931 ± 84 1809 ± 91 2162 ± 38 787 ± 29
21  202 ± 7 2198  183 ± 16 114,232 ± 895 4537 ± 194 96,644 ± 142 8817 ± 47 68,276 ± 84 1579 ± 90 2131 ± 39 810 ± 31
28  210.67 ± 2.08 1868 245 ± 15 105,062 ± 889 4721 ± 194 94,448 ± 144 8484 ± 47 67,493 ± 85 1581 ± 103 1944 ± 38 700 ± 28
Treated  group
1  159.67 ± 12.22 1367 10,253 ± 38 88,899 ± 763 3772 ± 165 70,786 ± 117 8407 ± 41 59,227 ± 73 1327 ± 74 1861 ± 31 679 ± 21
5  172 ± 8.66 2058 238 ± 15 100,980 ± 866 4852 ± 192 93,630 ± 139 8427 ± 46 70,340 ± 84 1799 ± 92 2101 ± 38 772 ± 26
6  174.33 ± 8.38 1980 4021 ± 29 96,798 ± 934 5092 ± 213 88,677 ± 146 9521 ± 50 67,331 ± 90 1714 ± 91 2141 ± 39 823 ± 27
7  179 ± 11.27 2807 4080 ± 29 103,006 ± 967 4741 ± 221 93,058 ± 153 11,338 ± 54 69,801 ± 92 1711 ± 95 2307 ± 40 846 ± 27
8  187 ± 12.12 3709 2885 ± 21 80,497 ± 703 3218 ± 155 68,949 ± 110 6343 ± 37 46,479 ± 63 1420 ± 87 1553 ± 31 540 ± 22
9  189.67 ± 10.79 2470 3782 ± 25 83,898 ± 747 3856 ± 164 77,419 ± 119 6520 ± 39 59,015 ± 74 1619 ± 94 1700 ± 33 627 ± 23
10  195.33 ± 8.74 3483 4330 ± 28 106,045 ± 892 3875 ± 196 82,598 ± 136 8378 ± 46 60,411 ± 82 1415 ± 74 1974 ± 35 693 ± 24
11  196 ± 10.82 2713 794 ± 18 107,286 ± 894 4256 ± 202 93,118 ± 141 8652 ± 48 67,501 ± 84 1697 ± 94 2147 ± 40 766 ± 31
12  197 ± 13.23 2251 253 ± 14 100,294 ± 841 4639 ± 185 84,467 ± 131 7819 ± 44 64,113 ± 81 1542 ± 82 1950 ± 36 727 ± 26
14  203.67 ± 16.26 2743 4082 ± 28 102,233 ± 862 4212 ± 190 83,496 ± 133 7534 ± 45 59,935 ± 78 1619 ± 86 1898 ± 38 688 ± 29
21  219 ± 21 3027 7957 ± 40 109,912 ± 966 4742 ± 218 96,900 ± 152 9114 ± 52 71,921 ± 91 1738 ± 91 2164 ± 44 841 ± 36
28  235.67 ± 25.42 2279 4783 ± 30 98,746 ± 882 4508 ± 194 90,908 ± 141 8524 ± 48 65,099 ± 84 1495 ± 97 1984 ± 39 756 ± 29
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Fig. 6. PIXE analyses of rat feces during subacute administration of 50 mg kg−1 day−1 of TiC from selected days. TiC administration was done only during
ontrol c
tatistica
1; +++, *weekdays.  All plots have been normalized with respect to rat weight and c
Zn.  Statistical analysis: two way ANOVA using the Holm–Sidak method. S
(*),  control animals (×). +, *, × indicate p < 0.05; ++, **, ×× indicate p < 0.0
of the used products. For example: particle size distri-
bution (i.e. change from pristine to dispersed powders),
crystallinity (i.e. anatase or rutile for TiO2), surface area
(porosity), and chemical composition (surface and bulk).
Such  reported parameters could have explained apparent
differences of similar experiments using supposedly sim-
ilar  NMs, i.e. SWCNT [34] or TiO2 NPs [35,36]. Secondly,
the use of non-standardized or in-house protocols. These
points  are subjects of attention, for example there are cur-
rently  several European projects aiming to address this
issue  in speciﬁc areas, such as QualityNano (http://www.
qualitynano.eu/), NanoValid (http://www.nanovalid.eu/),
and  NanoReg (http://www.nanoreg.eu/). To avoid the
aforementioned pitfalls, the present study has extensive
physicochemical characterization of the used TiC product
and  followed standardized animal exposure protocols.
4.1. Physicochemical properties of TiC
When nanomaterials (NMs) enter into a biological
medium they are surrounded by proteins and lipids, and
an  interaction medium-NMs takes place by the formation
of  a hard corona [37,38]. Nevertheless, the link between
NMs  properties, hard corona formation and toxicological
response is unclear. Hence, there is a need for extensiveoncentrations. Variation of: (A) Ti, (B) Mg,  (C) Al, (D) P, (E) S, (F) Ca and (H)
l signiﬁcance between: control and treated animals (+), treated animals
**, ××× indicate p < 0.001. The trend lines are guides to the eye.
physicochemical characterization of NMs. The dispersion
conditions selected for TiC minimized the NPs surface alter-
ation,  as similarly done in an in vivo silicon carbide (SiC)
NPs  study [31]. Seventy-ﬁve percent of TiC is below 100 nm
under  the dispersion conditions, therefore the TiC in this
study  is a nanomaterial product according to the recom-
mendation of the European Commission for the deﬁnition
of  a nanomaterial: >50% particles in number are <100 nm
[39].  The pass of TiC through rat gastric ﬂuid is not expected
to  alter signiﬁcantly the particle size distribution, as shown
in  a study that the decrease in TiC primary particles when
exposed to reconstituted gastric ﬂuid is 1.3–5% [20].
4.2.  Toxicity
Acute and subacute assessments were based from cur-
rent  OECD guidelines [21,23], where adaptations took place
in  terms of the used doses due to technical limitations, i.e.
high  doses resulted into mud-like suspensions. Acute and
subacute  in vivo oral administration assessments are rel-
evant  in light of the potential toxicological-related effects
that  NMs  can exert, such as: NMs  capacity to pass across
the  intestinal barrier [40], possible NMs  accumulation and
damage  exerted to key organs (GI tract, liver, kidneys,
spleen) and the cardiovascular system [17,41], effects in
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Fig. 7. Diuresis (mL) (A), daily osmolarity (B), sodium (C) and potassium (D) excretion during subacute administration. Mean ± SD, n = 3. () Shows the
data  from the control group; () shows the data from the 0.5 mg  kg−1 TiC treated group and () shows the data from the 50 mg kg−1 TiC treated group.
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. (A) 24
C) showFig. 8. FEG-SEM images of TiC in the urine ﬁltered through a 450 nm mesh
after  50 mg  kg−1 subacute administration, (D) EDX from selected area in (
blood serum [42], and the possible alteration to urinary
parameters (potassium, sodium, osmolarity) which can be
used  as alternative biomarkers to track down the effects of
NMs  in the bloodstream.
Histological analyses showed no signs of morphological
alterations, granulomas or tissue damage, in the analyzed
sections with respect to the control group. This result
applied for both acute and subacute TiC administrations in
the  GI tract, liver, kidneys and spleen. Given the lack of mor-
phological alterations, immunochemistry assays were not
pursued.  These negative effects may  be correlated to the
fact  that TiC is mostly eliminated via feces in a short period
of  time. In contrast TiO2 NPs are more toxic. In vivo studies
with  TiO2 NPs on male and female CD-1 mice via intra-
gastric administration at similar doses and particle sizes
to  those used in this study found liver hydropic degener-
ation and necrosis at a dose of 5 g kg−1 TiO2 and kidney
proteinic liquids in renal tubules and glomerulus swelling
[43,44]. Exposure of SiC under similar conditions to those
of  this study has been reported [31], showing that these
NPs  induced no morphological alteration when compared
to  the control group.
Alteration  of plasma biochemical parameters reveals
modiﬁcations in the blood enzymes, which may  indicate a
series  of events, for example systemic leakage from intra-
cellular  sites or target tissues due to cellular or tissue injury
[58].  In the present study, within the acute administra-
tion assessment (0.5, 5, 50, 300 and 1000 mg  kg−1) there
was  a signiﬁcant decrease in the plasmatic AP in three of
the  treated groups. Similarly, ASAT increased for the high-
est  administered dose group, and bile salts decreasing for
the  lowest dose group. For the subacute administration h after 0.5 mg  kg−1 acute administration, (B) zoom in of (A and C) 28 days
ing the presence of Ti, see arrows.
assessment (0.5 and 50 mg  kg−1), no biochemical param-
eter was  altered, reﬂecting that alterations in plasmatic AP
or  bile salts from low dose acute administration are not rel-
evant  for a context of chronic exposure under the studied
doses. In comparison, subacute intragastric administration
of TiO2 to male and female Wistar rats led to an increase
in WBC, LYMs, MONs and EOS blood parameters [44,45].
Subacute administration of SiC in Sprague Dawley female
rats  resulted in a statistical decrease of plasmatic urea in
the  50 mg  kg−1 exposed group [31].
No  differences were found in the urinary parameters
between the control and TiC exposed groups. In contrast
exposed groups to SiC under the same conditions to this
study  found a marked reduction in the osmolarity of the
treated  groups with respect to the control group [31].
In  summary, from a toxicity point of view, TiC
causes markedly less alterations under similar exposure
conditions than its metal-oxide (TiO2) and metal-carbide
counterparts (SiC). Such differences are based on the differ-
ent  physical and chemical properties of the materials such
as  the crystallinity and surface area. Titanium dioxide NPs
have  a toxicity associated with their crystalline structure,
anatase and rutile, and their associated chemical reactivity
to  induce reactive oxygen species (ROS) [46]. In this sense,
TiC  NPs have a mixed surface composed of TiO2 and C
compounds; however, their crystalline structure is that of
cubic  TiC without any other phases indicating the presence
of  crystalline TiO2, see Table 1. The speciﬁc surface area
of  SiC NPs used by Lozano et al. [31], was 30 m2 g−1, about
two-fold higher than that of 16 m2 g−1, the speciﬁc surface
area of TiC NPs used in this study. Both their primary
particle sizes are similar, 23 versus 18 nm for SiC and TiC,
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espectively. Therefore, the higher surface area of SiC
Ps  resulted in the formation of a protein corona that
ould interact with more proteins and molecules in the
urrounding environment (i.e. blood, urine) hence causing
ore  alterations to the urinary and plasma biochemical
arameters than TiC counterparts. The results points out
hat  it is within a range from 16 to 30 m2 g−1 where this
iological alterations can be detected in rats assuming
 lack of chemical reactivity in the NPs, like the case of
rystalline TiO2 [47].
.3.  Biodistribution of TiC and elemental composition
hanges to feces and organs
The  concentration of TiC in feces for the acute admin-
stration demonstrates that it is expelled within one day
fter  administration, faster than SiC NPs studied under the
ame  conditions [31]. This result is in agreement with the
esults  from subacute administration during the weekend
no  administration on those days) where the Ti concen-
ration dropped to control concentration. These control
oncentration of Ti are, as mentioned Section 3, due to
he  Ti content found in the rat food. The concentration of
iC  measured per day had very little variation, as reﬂected
y  the small error bars. The day-to-day ﬂuctuations seem
o  suggest variability due to the not homogenous suspen-
ion  in the stock solution, inducing variability in the daily
reparation of the suspension.
PIXE measurements offer the advantage of multi-
lemental acquisition, and thus all the elements found in
he  feces were acquired from Mg  up to zinc (Zn). A response
o  TiC administration was observed in rats as a change in the
oncentration of some elements in the excreted feces with
espect  to the control group. These changes were observed
n  the subacute administration for all measured minerals.
or  all of them the same trend is observed despite the dif-
erences  in the concentration. This trend as exempliﬁed in
ig.  6B for days 1–14 shows that with respect to the control
alues, a higher mineral absorption (value lower than 1.0)
s  directly related to TiC administration, a tendency that
everts  (mineral excretion, value higher than 1) when it is
ot  administered. The increase in absorption is 45–50% on
ay  1, diminishing down to 16–28% on day 28. The second
ey  element is that during the days without administration
here is a higher fecal excretion from those elements than
ontrol  samples, suggesting a lower absorption through
he  GI tract. The highest absorption reduction took place
n  the ﬁrst weekend, here shown day 5, with 49–107%.
he reduction in ﬂuctuation amplitude from the ﬁrst to the
econd  weekend suggests that the administration of TiC
nﬂuences less with time the absorption of elements from
he  eaten food. Similarly the absorption increase during
xposure days going from 45–50% (day 1) down to 16–28%
day  28) supports this hypothesis. The ﬂuctuations on these
lements  may  have important repercussions. For example,
oth  Ca2+ and PO4−3 ions control the many essential cellu-
ar processes [48]. Variations in their supply, although not
nducing  an immediate short term toxicity effect or per-
eptible damage on either the GI tract or liver and kidneys,
ay  present long term repercussions such as changes in
he  mitochondrial function, apoptotic cell death or bonerts 1 (2014) 172–187 185
metabolism [48]. Magnesium is involved in the synthesis
of  DNA, RNA and proteins, and plays a complementary role
with  Ca as a long-term regulatory element [49]. Reddy et al.
found  that Ca, P and Mg are reduced in feces excretion for
rats  without intestinal microﬂora [50], implying that the
rats  in this study could have had their microﬂora altered
due  to TiC administration. Variations in absorbed Al could
be  related to alterations to the sites of Al absorption, the
small  intestine and colon [51]. Iron is required to capture
energy from food oxidation and enables oxygen transport
to  tissue through the hemoglobin in the red blood cells;
however, abnormal regulation of Fe uptake leads to disease
of  the liver and other organs [52]. Excess Zn intake leads
to  symptoms of anemia and impaired immune function
[53]. In all, these variations may  cause long-term effects in
bone  metabolism and cellular signaling, and may  produce
pathological conditions.
The  biodistribution of TiC was  studied in rat liver, kid-
neys  and spleen after a single administration and sacriﬁce
either  1 or 7 days later. These organs are important for
the  translocation of NMs  from the intestinal barrier to
the  bloodstream and their eventual renal ﬁltration. For
example the liver is the primary organ involved in the
metabolism and detoxiﬁcation of xenobiotics [54]. In the
liver,  the Ti concentration in the treated group was like the
control  samples. For kidneys the Ti concentration was  simi-
lar  on both days, lower than control samples. For the spleen
there  was a reduction in Ti concentration on day 1. Simi-
larly  the organ mineral contents were analyzed. Most of
them  were either higher or lower than control concentra-
tions. In general, the liver and kidneys followed contrary
changes in comparison to the spleen. For example the con-
centrations of P, S and Zn were higher on day 1 than day
7  in the liver and kidneys but inverse for the spleen. For
the  liver the concentration of Al was  signiﬁcantly higher
on  day 1, while for spleen the difference in Ca concentra-
tion between days 1 and 7 was  statistically signiﬁcant. In
summary, the administration of TiC causes alterations to
the  absorbed minerals which are reﬂected also as alter-
ations in the minerals observed at different organs, and
such  variations in organs can even be traced after a single
administration up to 7 days later. In comparison to the same
study  using SiC NPs, TiC causes lower impact alterations to
the  mineral content in organs [31].
The studied TiC was found able to cross from the intesti-
nal  barrier and reach the blood stream, as observed in traces
in  urine. Other NMs  have been found to cross the intesti-
nal  barrier, like SiC NPs [31] and Au NPs [40]. Studies with
carbon-based NMs  have similarly found a low percentage
cross of the intestinal barrier, like carbon nanotubes [55,56]
and 14C functionalized fullerenes which were 98% cleared
in  feces within 48 h and the other 2% excreted through urine
[17,57].
5.  Conclusion
The effects of a TiC oral administration were minimal
and do not pose a threat in the short-term. Those effects
were: an alteration to the mineral absorption through the
GI  tract, likely a result of alteration the intestinal microﬂora,
and  alterations in the organs mineral content and the
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plasma AP, ASAT and bile salts. A very small amount of
TiC  passed through the GI tract and was excreted in urine.
Therefore, the results presented in this study indicate that
under  the studied doses TiC NPs do not induce toxicity to
rats  via the GI pathway by oral administration. An aerosol
exposure study should complete the evaluation of the TiC
NPs  potential to induce toxicity.
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